FDA approves updated Covid-19 vaccines for dominant XFG variant
Decision allows manufacturers to begin shipping doses, but confusion remains about insurance coverage The US Food and Drug Administration approved updated Covid-19 vaccines on Thursday, allowing manufacturers to begin shipping doses to pharmacies and doctors’ offices across the country. The FDA approved Moderna, Novavax-Sanofi and Pfizer-BioNTech’s updated Covid vaccines, the companies said on Thursday, after an advisory panel recommended that the shots should target the dominant XFG variant.
The Guardian2 sources
Published by CurrentWire · First coverage · Latest coverage
Compiled by CurrentWire News Desk
Summary based on reporting from The Guardian and The Hill.
Coverage at a glance
- First observed by CurrentWire: The Hill · Aug 27, 2026 at 7:18 PM ET
- Coverage span: 2h 0m
- Coverage: 2 reports from 2 independent publications
- Coverage growth: 1 → 2 publications in 1h 59m
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
2 publications are covering this story.
Excerpts are the summaries each publisher distributes with its own feed, shortened and attributed.
The GuardianTier B
FDA approves updated Covid-19 vaccines for dominant XFG variant(opens original report in a new tab)The HillTier B
FDA approves new COVID-19 shots(opens original report in a new tab)The Food and Drug Administration approved updated COVID-19 vaccines on Thursday for people at higher risk, clearing the way for manufacturers to begin shipping them to pharmacies and physicians’ offices. The agency… — The Hill
How coverage developed
First report from The Hill
Reported by The Guardian
Story updateHeadline updated
Story updateThe Guardian joined coverage
Story updateHeadline updated
Story updateHeadline updated
Story updateCoverage went from 1 to 2 sources
How CurrentWire compiled this story
The Guardian (www.theguardian.com), a Tier B publisher, filed this report on . CurrentWire published this page 12 minutes later, on .
Signal breakdown
CurrentWire ranked this story 76.5 of 100 in the snapshot this page was rendered from.
- Freshness
- 31.6 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 8.5 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 10 of 10
- Velocity
- 2.5 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under Health · United States · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: FDA (7), COVID-19 (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.